Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natasha T Strande

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Frontiers in Genetics|June 13, 2022
A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare SystemLaney K Jones, Natasha T Strande, Evan M Calvo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 11, 2025
Monogenic disorders associated with motor speech phenotypes in children and adolescents undergoing clinical exome sequencingMarissa W Mitchel, Matthew Oetjens, Alexander S F Berry, et al.
Journal of Medical Genetics|April 30, 2025
Rare missense variants in <i>FNDC1</i> are associated with severe adolescent idiopathic scoliosisWu-Lin Charng, Gabe Haller, Julia Whittle, et al.
JAMA Network Open|March 17, 2025
Genomic Screening at a Single Health SystemJuliann M Savatt, Melissa A Kelly, Amy C Sturm, et al.
Journal of the American Heart Association|June 29, 2023
Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data ScreeningSamuel S Gidding, H Lester Kirchner, Andrew Brangan, et al.
JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.
HGG Advances|October 1, 2023
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variantsKelvin C de Andrade, Natasha T Strande, Jung Kim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2015
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencingJonathan S Berg, Ann Katherine M Foreman, Julianne M O'Daniel, et al.
The Journal of Pediatrics|March 11, 2019
An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn ScreeningLaura V Milko, Julianne M O'Daniel, Daniela M DeCristo, et al.
American Journal of Human Genetics|May 30, 2017
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome ResourceNatasha T Strande, Erin Rooney Riggs, Adam H Buchanan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Frontiers in Genetics|June 13, 2022
A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare SystemLaney K Jones, Natasha T Strande, Evan M Calvo, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 11, 2025
Monogenic disorders associated with motor speech phenotypes in children and adolescents undergoing clinical exome sequencingMarissa W Mitchel, Matthew Oetjens, Alexander S F Berry, et al.
Journal of Medical Genetics|April 30, 2025
Rare missense variants in <i>FNDC1</i> are associated with severe adolescent idiopathic scoliosisWu-Lin Charng, Gabe Haller, Julia Whittle, et al.
JAMA Network Open|March 17, 2025
Genomic Screening at a Single Health SystemJuliann M Savatt, Melissa A Kelly, Amy C Sturm, et al.
Journal of the American Heart Association|June 29, 2023
Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data ScreeningSamuel S Gidding, H Lester Kirchner, Andrew Brangan, et al.
JAMA|January 24, 2023
Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical PopulationDavid B Beck, Dale L Bodian, Vandan Shah, et al.
HGG Advances|October 1, 2023
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variantsKelvin C de Andrade, Natasha T Strande, Jung Kim, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 14, 2015
A semiquantitative metric for evaluating clinical actionability of incidental or secondary findings from genome-scale sequencingJonathan S Berg, Ann Katherine M Foreman, Julianne M O'Daniel, et al.
The Journal of Pediatrics|March 11, 2019
An Age-Based Framework for Evaluating Genome-Scale Sequencing Results in Newborn ScreeningLaura V Milko, Julianne M O'Daniel, Daniela M DeCristo, et al.
American Journal of Human Genetics|May 30, 2017
Evaluating the Clinical Validity of Gene-Disease Associations: An Evidence-Based Framework Developed by the Clinical Genome ResourceNatasha T Strande, Erin Rooney Riggs, Adam H Buchanan, et al.
Pageof 4